Dr. Hsian-Rong Tseng

Professor of Molecular and Medical Pharmacology, UCLA
Hsian-Rong Tseng
Prof. Hsian-Rong (HR) Tseng is a Molecular & Medical Pharmacology Professor at the David Geffen School of Medicine at UCLA. On the UCLA campus, he also holds joint memberships in the California Nano Systems Institute, Crump Institute for Molecular Imaging and Jonsson Comprehensive Cancer Center. At the UCLA Liquid Biopsy Laboratory, which he co-directs, Prof. Tseng and his team develop in vitro diagnostics (IVD) technologies for use in oncology and perinatology. He founded CytoLumina Technologies Corp. and Eximius Diagnostics to commercialize these platform technologies. Under Prof. Tseng's leadership, CytoLumina's NanoVelcro Chips was recognized as a Success Story by the National Cancer Institute (NCI) Innovative Molecular Analysis Technologies (IMAT) program in October 2019. Prof. Tseng earned his Ph.D. in Chemistry from National Taiwan University in 1998 and completed a postdoctoral fellowship in UCLA Chemistry under the supervision of Professor Sir Fraser Stoddart, the 2016 Nobel Laureate in Chemistry.
September 28
Biopharma session

No Digital PCR Festival would be complete without exploring the use of digital PCR in biopharmaceutical manufacturing. Discover how scientists apply dPCR in cell and gene therapies where precision and sensitivity are of highest importance.

  • Opening remarks from QIAGEN
  • PCR in Biopharma - Past, Present, and the Future
    Speaker: Prof Dr. Mikael Kubista, Institute of Biotechnology, Czech Academy of Sciences, Czech Republic
  • Digital PCR Empowers Liquid Biopsy for Comprehensive Solid Tumor Management: Integrating Circulating Tumor Cells and Extracellular Vesicles
    Speaker: Prof Dr. Hsian-Rong Tseng, David Geffen School of Medicine at UCLA, USA
  • Multiplex dPCR offers quantitative viral vector genome integrity evaluation
    Speaker: Assist. Prof. Dr. David Dobnik, Niba Labs d.o.o. , Slovenia
  • Digital PCR Applications for Gene Therapy Products Including AAV Quantitation
    Speaker: Mr. Stuart Nelson, Eli Lilly and Company, USA
  • Quantifying AAV vector genome titer in process  ̶  intermediate samples by digital PCR and digital droplet PCR (d/dPCR)
    Speaker: Mr. Chieme Kennedy Okechukwu, National Resilience, USA
  • Closing remarks from QIAGEN
Dr. Mikael Kubista and 4 other experts